Every finished pharmaceutical product for human or animal use in Thailand needs drug registration with the Thai FDA. Only then can it be imported, manufactured, or ordered into the Kingdom.
Thailand’s drug-registration requirements depend on the product type, its risk profile, the manufacturing location, and the intended purpose of importation or use. Depending on the product, applicants may need to address facility licensing, product registration, GMP Clearance, quality and safety documentation, labelling, import requirements, and post-marketing obligations.
In this article, companies can find the regulation and registration process of drugs and pharmaceutical products intended for human use.
Who Approves Drugs/Pharmaceutical Products in Thailand?
The Thai Food and Drug Administration, under Thailand’s Ministry of Public Health, is the principal authority responsible for drug registration and approval. The approval framework has two connected parts. Drug facility licensing covers manufacturers, importers, and other relevant establishments. Pharmaceutical product registration and approval covers the individual medicine or pharmaceutical product.
For foreign manufacturers, the application must generally be handled through an appropriately licensed Thai establishment or local applicant. The local party may act as the applicant, importer, or marketing-authorisation holder, depending on the arrangement and the applicable Thai requirements.
Pharma Product Categories for Regulations in Thailand
In practice, Thai FDA requirements depend on the product’s legal status, intended use, risk profile, manufacturing or importation status, and the applicable registration or notification pathway.
Relevant pathways may include:
- Finished pharmaceutical products for human or animal use;
- New drugs and new biological products;
- Generic and new generic drugs;
- Human vaccines and plasma-derived products;
- Active pharmaceutical ingredients used in drug manufacturing;
- Low-risk medicinal products;
- Products imported for specific purposes, including registration samples, clinical trials, analysis, donations, and exhibitions;
- Products subject to special import restrictions or additional certification requirements.
The Thai FDA maintains separate guidance and procedures for modern drug registration, low-risk medicinal-product registration, electronic submissions, drug-registration renewals, pharmaceutical chemicals, traditional medicines, and veterinary medicines.
Thai FDA Drug Pre-registration Requirements
Before submitting a pharmaceutical-product registration application, the applicant must first determine the applicable facility and product requirements.
For a conventional finished pharmaceutical product, the applicant may need to establish or identify:
- The appropriate Thai applicant, importer, or local establishment;
- The relevant drug-facility licence, where applicable;
- The product’s regulatory category and registration pathway
- Manufacturing-site and GMP documentation
- Product composition, specifications, and manufacturing information
- Stability and quality data
- Proposed labels and package inserts
- Clinical, safety, efficacy, or bioequivalence data, where it applies
- Any additional documents required for the specific product type.
The Thai FDA states that, after obtaining the relevant drug-facility license, a licensed manufacturer or importer must register the product intended to be manufactured or imported. The registration documents must be prepared according to the ASEAN Common Technical Dossier (ACTD) or the ICH Common Technical Document (ICH CTD), depending on the applicable requirements.
To simplify your Thai FDA registration process, companies can also seek support through Artixio’s Pharma Regulatory Affairs Services in Thailand.
Documents Required by TFDA for Drug Approval
The documents required for each module of the regulatory process may vary depending on the category of product. Risk, registration route, and technical guidelines that apply will also affect the dossier. Companies may consider the following things to add to their document list:
- Administrative and applicant information
- Product composition and product information
- Proposed labels and package inserts
- Manufacturing process and quality-control information
- Specifications and analytical methods
- Stability data
- Preclinical and clinical data, where required
- Bioavailability or bioequivalence data, where applicable
- GMP documentation
- Information related to safety, efficacy, and risk-benefits
- Pharmacovigilance or risk-management information, where it’s needed
- Evidence that supports the proposed indications and dosage
- Additional documents needed under a specific notification or registration pathway
The ASEAN Common Technical Dossier (ACTD) or the ICH Common Technical Document (ICH CTD) can help prepare the relevant dossiers. It depends on which requirements apply.
Pharmaceutical Products Registration Process in Thailand
The registration route is not the same for every pharmaceutical product category for human use and the application path. The general steps include the following:
Step 1: Identify the Eligible Applicant and Facility Route
Foreign manufacturers should recognize the appropriate Thai applicant, importer, or local establishment. Confirm whether the relevant drug-facility license is required before product registration.
Step 2: Know the Product Category & Registration Pathway
The applicant should decide if the product is a new drug, a generic drug, a new generic drug, a biological product, a vaccine, a low-risk medicinal product, an API, or another regulated category. The documents, review process, and additional approvals depend on the
Step 3: Arrange the Technical Dossier
The dossier should be prepared in the required ACTD or ICH CTD format, together with the applicable administrative documents, product information, quality data, stability information, clinical or bioequivalence data, and proposed labeling.
Step 4: Submit the Application
The application is submitted through the applicable Thai FDA process, including electronic submission where required or permitted.
Step 5: Review
The Thai FDA reviews the submission for completeness. They evaluate the quality, safety, efficacy, and other supporting information according to the product type and pathway.
Step 6: Manufacturing and GMP-Site Review
GMP documentation and manufacturing-site compliance may be reviewed as part of the applicable process. The precise requirement depends on the manufacturing location, product type, and relevant Thai FDA process.
Step 7: Approval & Post-Approval Compliance
The Thai FDA may grant the matching product approval or registration if the application satisfies the applicable requirements. The applicant must then comply with any conditions attached to the approval, as well as applicable importation, distribution, labeling, renewal, variation, and post-market obligations.
Artixio supports pharmaceutical companies with product registration services in Thailand.
GMP Inspection Requirements for Pharmaceutical Products in Thailand
Applicants may need to provide manufacturing-quality documentation. The manufacturing facilities must meet the standards required by the Thai FDA. The precise GMP evidence and inspection requirements depend on the product, manufacturing location, and relevant registration or importation procedure.
Therefore, GMP should not be described as one identical inspection process for every product. Thai FDA also lists separate requirements concerning evidence that pharmaceutical chemicals are produced at manufacturing sites with manufacturing-quality certification.
Thai FDA Labeling Requirements for Drug Registration
Pharmaceutical labeling must comply with the applicable Thai FDA requirements and the requirements for the relevant product category. Thai-language labeling or Thai-language product information may be required, depending on the product and applicable procedure.
Typical labeling and package-insert information may include:
- Product name
- Active ingredient or ingredients
- Strength and dosage form
- Directions for use
- Warnings and precautions
- Storage conditions
- Other information required by the applicable drug-labeling requirements.
Thai FDA’s official materials include requirements concerning the display of drug labels under the Drugs Act and related amendments. The Thai FDA also maintains electronic-submission guidance for modern drug registrations, which should be checked when preparing electronic product information and supporting documents.
Timelines & Fees for Drug Registration in Thailand
Timelines vary according to the product type, dossier completeness, review pathway, questions raised during assessment, and whether a special or reliance procedure is used. Applicants should confirm current fees directly with Thai FDA before budgeting for a registration project.
Import and Distribution Requirements of Pharmaceutical Products in Thailand
Product registration is not necessarily the final regulatory step before a medicine can be distributed in Thailand.
Depending on the product and activity, the applicant may also need to comply with drug-facility licensing, importation requirements, distribution requirements, product-specific import permissions, lot-release requirements, restrictions applicable to certain drugs, and conditions attached to the product registration.
Thai FDA specifically identifies the following additional procedures:
- Human vaccines and plasma-derived pharmaceutical products may require a Certificate of Lot Release from the Department of Medical Sciences before distribution or handover to users.
- Certain products listed under Ministry of Commerce notifications may require an FDA approval certificate before import permission is sought from the Ministry of Commerce.
- Drugs subject to strict import restrictions may require additional approval before importation.
- Medicines imported for registration samples, clinical trials, analysis, donations, or exhibitions are subject to specific procedures.
Post-Marketing Activities
After a pharmaceutical product is approved and launched in the market, companies need to comply with post-marketing activities. These activities include pharmacovigilance to monitor and report adverse drug reactions. Companies may also need to apply for variations to the product registration, such as changes to the dosage form or strength. Additionally, periodic renewal of the product registration is required by the TFDA. Compliance audits may also be conducted to ensure ongoing adherence to regulations.
Additional Regulatory Considerations
Check out other regulatory conditions concerning drugs and pharmaceutical products:
Active Pharmaceutical Ingredients
Active pharmaceutical ingredients used as raw materials for drug manufacturing are not handled in exactly the same way as finished pharmaceutical products. The Thai FDA states that APIs must be notified to the authority before they are manufactured, imported, or ordered into Thailand. Their manufacturing facilities must also meet applicable manufacturing standards, such as GMP.
Products Imported for Specific Purposes
The Thai FDA identifies specific procedures for medicines imported or manufactured for registration samples, human clinical trials, analysis, donations to healthcare facilities, and exhibitions. These procedures should not be treated as ordinary commercial product-registration applications.
Traditional and Veterinary Medicines
Traditional medicines and modern veterinary medicines are listed separately in the Thai FDA’s regulatory materials. Their registration requirements should therefore be reviewed under the relevant product-specific guidance.
Conclusion
The Thailand drug approval process is provided by the Thai FDA, which works at its own pace. A lot of it depends on how the documentation and local coordination are handled along the way. Artixio provides pharmaceutical regulatory services in Thailand to help companies meet Thai FDA requirements for product registration and market entry.
FAQs
1. Do human vaccines and plasma-derived medicines require additional approval after Thai FDA registration?
Yes. Human vaccines and plasma-derived pharmaceutical products may require a Certificate of Lot Release from the Department of Medical Sciences’ Institute of Biological Products before they can be distributed or supplied to users. Product registration alone may therefore not be the final regulatory step for these products.
2. Do active pharmaceutical ingredients need to be registered in Thailand?
Active pharmaceutical ingredients (APIs) are treated separately from finished pharmaceutical products. APIs used for drug manufacturing must generally be notified to the Thai FDA before they are manufactured, imported, or ordered into Thailand. The facilities manufacturing these pharmaceutical chemicals must also meet applicable manufacturing standards, such as GMP requirements.
3. Can individuals bring medicines into Thailand for personal use without a commercial import license?
A traveller may generally bring modern medicines into Thailand for personal use for no more than 30 days, provided the medicines are kept in their original containers and accompanied by the doctor’s prescription. Travellers should verify the current conditions and any additional restrictions, particularly for controlled, psychotropic, or narcotic substances, before travelling.
4. Can Previous EU or US Approval Support Thai FDA Drug Registration?
Previous approval in the European Union or the United States does not automatically grant Thai marketing authorization. However, it may support an eligible formal reliance or Collaborative Registration Procedure (CRP) pathway. The 2025 Thai FDA CRP notification identifies pathways involving standard registration, WHO Collaborative Registration Procedure, and Stringent Regulatory Authority Collaborative Registration Procedure.
